Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

1,404 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Lutetium-177-PSMA-617 for Metastatic Castration-Resistant Prostate Cancer.
Sartor O, de Bono J, Chi KN, Fizazi K, Herrmann K, Rahbar K, Tagawa ST, Nordquist LT, Vaishampayan N, El-Haddad G, Park CH, Beer TM, Armour A, Pérez-Contreras WJ, DeSilvio M, Kpamegan E, Gericke G, Messmann RA, Morris MJ, Krause BJ; VISION Investigators. Sartor O, et al. Among authors: herrmann k. N Engl J Med. 2021 Sep 16;385(12):1091-1103. doi: 10.1056/NEJMoa2107322. Epub 2021 Jun 23. N Engl J Med. 2021. PMID: 34161051 Free PMC article. Clinical Trial.
[18F-FDG-PET in therapy response of esophageal cancer].
Wieder HA, Herrmann K, Ott K, Krause BJ. Wieder HA, et al. Among authors: herrmann k. Radiologe. 2007 Feb;47(2):110-4. doi: 10.1007/s00117-006-1461-9. Radiologe. 2007. PMID: 17225182 Review. German.
Early metabolic response evaluation by fluorine-18 fluorodeoxyglucose positron emission tomography allows in vivo testing of chemosensitivity in gastric cancer: long-term results of a prospective study.
Ott K, Herrmann K, Lordick F, Wieder H, Weber WA, Becker K, Buck AK, Dobritz M, Fink U, Ulm K, Schuster T, Schwaiger M, Siewert JR, Krause BJ. Ott K, et al. Among authors: herrmann k. Clin Cancer Res. 2008 Apr 1;14(7):2012-8. doi: 10.1158/1078-0432.CCR-07-0934. Clin Cancer Res. 2008. PMID: 18381939
[11C]Choline as pharmacodynamic marker for therapy response assessment in a prostate cancer xenograft model.
Krause BJ, Souvatzoglou M, Herrmann K, Weber AW, Schuster T, Buck AK, Nawroth R, Weirich G, Treiber U, Wester HJ, Ziegler SI, Senekowitsch-Schmidtke R, Schwaiger M. Krause BJ, et al. Among authors: herrmann k. Eur J Nucl Med Mol Imaging. 2010 Oct;37(10):1861-8. doi: 10.1007/s00259-010-1493-2. Epub 2010 May 30. Eur J Nucl Med Mol Imaging. 2010. PMID: 20512572
PET and PET-CT in esophageal and gastric cancer.
Wieder HA, Krause BJ, Herrmann K. Wieder HA, et al. Among authors: herrmann k. Methods Mol Biol. 2011;727:59-76. doi: 10.1007/978-1-61779-062-1_5. Methods Mol Biol. 2011. PMID: 21331929
The sensitivity of [11C]choline PET/CT to localize prostate cancer depends on the tumor configuration.
Souvatzoglou M, Weirich G, Schwarzenboeck S, Maurer T, Schuster T, Bundschuh RA, Eiber M, Herrmann K, Kuebler H, Wester HJ, Hoefler H, Gschwend J, Schwaiger M, Treiber U, Krause BJ. Souvatzoglou M, et al. Among authors: herrmann k. Clin Cancer Res. 2011 Jun 1;17(11):3751-9. doi: 10.1158/1078-0432.CCR-10-2093. Epub 2011 Apr 14. Clin Cancer Res. 2011. PMID: 21493868
1,404 results